Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-541468 dose-response in elderly insomnia
NCT02841709Phase 2Completed
- Sponsor
- Idorsia
- Start
- Nov 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of daridorexant in insomnia disorder, sponsored by Idorsia. Started Nov 2016; status: completed.
02
Drugs
daridorexant
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT02841709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02841709.